ACE2 Protéines
(Angiotensin I Converting Enzyme 2 (ACE2))
The protein encoded by this gene belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. The organ- and cell-specific expression of this gene suggests that it may play a role in the regulation of cardiovascular and renal function, as well as fertility. In addition, the encoded protein is a functional receptor for the spike glycoprotein of the human coronaviruses SARS and HCoV-NL63. [provided by RefSeq, Jul 2008].
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| ACE2 Protein (AA 19-615) (His tag) | Humain | Eukaryota |
|
361,90 €
Voir le prix
|
|
| ACE2 Protein (AA 19-615) (Fc Tag) | Humain | Eukaryota |
|
361,90 €
Voir le prix
|
|
| ACE2 Protein (AA 19-740) (His tag) | Humain | Eukaryota |
|
361,90 €
Voir le prix
|
|
| ACE2 Protein (AA 19-740) (His tag) | Humain | Eukaryota |
|
361,90 €
Voir le prix
|
|
| ACE2 Protein (AA 19-740) (HRP) | Humain | Eukaryota |
|
462,00 €
Voir le prix
|
|
| ACE2 Protein (AA 392-740) (His tag) | Humain | Bacteria |
|
302,50 €
Voir le prix
|
|
| ACE2 Protein (AA 391-740) (His tag) | Humain | Bacteria |
|
361,90 €
Voir le prix
|
|
| ACE2 Protein (PE,His tag) | Humain | HEK-293 Cells |
|
3.096,95 €
Voir le prix
|
|
| ACE2 Protein (Fc Tag) | Humain | Mammalian Cells |
|
730,00 €
Voir le prix
|
|
| ACE2 Protéine | Humain | Mammalian Cells |
|
730,00 €
Voir le prix
|
|
| ACE2 Protéine | Humain | Mammalian Cells |
|
867,00 €
Voir le prix
|
|
| ACE2 Protein (Fc Tag) | Humain | Mammalian Cells |
|
776,60 €
Voir le prix
|
|
| ACE2 Protein (His tag) | Souris | Escherichia coli (E. coli) |
|
503,00 €
Voir le prix
|
|
| ACE2 Protein (His tag) | Humain | Escherichia coli (E. coli) |
|
503,00 €
Voir le prix
|
|
| ACE2 Protein (His tag) | Humain | Escherichia coli (E. coli) |
|
503,00 €
Voir le prix
|
|
| ACE2 Protein (His tag) | Humain | Mammalian Cells |
|
730,00 €
Voir le prix
|
|
| ACE2 Protein (His tag) | Humain | Mammalian Cells |
|
730,00 €
Voir le prix
|
|
| ACE2 Protein (His tag) | Humain | Mammalian Cells |
|
730,00 €
Voir le prix
|
|
| ACE2 Protein (His tag) | Humain | Human Cells |
|
878,90 €
Voir le prix
|
|
| ACE2 Protein (AA 617-716) (His tag) | Souris | Bacteria |
|
361,90 €
Voir le prix
|
Protein
- Origine
- Humain
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- 90 %
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Origine
- Humain
- Hôte
- Mammalian Cells
- Type Proteine
- Recombinant
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Origine
- Humain
- Hôte
- Mammalian Cells
- Type Proteine
- Recombinant
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Origine
- Humain
- Hôte
- Mammalian Cells
- Type Proteine
- Recombinant
Protein
- Origine
- Humain
- Hôte
- Mammalian Cells
- Type Proteine
- Recombinant
- Pureté
- Greater than 95 % as determined by reducing SDS-PAGE.
- Activité biologique
- Active
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Origine
- Souris
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Origine
- Humain
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Origine
- Humain
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Origine
- Humain
- Hôte
- Mammalian Cells
- Type Proteine
- Recombinant
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Origine
- Humain
- Hôte
- Mammalian Cells
- Type Proteine
- Recombinant
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Origine
- Humain
- Hôte
- Mammalian Cells
- Type Proteine
- Recombinant
Protein
- Origine
- Humain
- Hôte
- Human Cells
- Type Proteine
- Recombinant
- Pureté
- Greater than 95 % as determined by reducing SDS-PAGE.
Dernières publications pour nos ACE2 Protéines
: "SARS-CoV-2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination." dans: Advanced materials (Deerfield Beach, Fla.), Vol. 32, Issue 50, pp. e2005637, (2021) (PubMed).
: "SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus." dans: Communications biology, Vol. 4, Issue 1, pp. 129, (2021) (PubMed).
: "Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2." dans: JCI insight, (2021) (PubMed).
: "SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity." dans: Nature communications, Vol. 12, Issue 1, pp. 848, (2021) (PubMed).
: "Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2." dans: International immunopharmacology, Vol. 90, pp. 107172, (2021) (PubMed).
: "Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library." dans: Protein science : a publication of the Protein Society, Vol. 30, Issue 4, pp. 716-727, (2021) (PubMed).
: "A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency." dans: Antiviral research, Vol. 194, pp. 105147, (2021) (PubMed).
: "38" dans: , Vol. 1363, Issue Nucleic acids research, pp. 28-39, (1991)
: "Identification of Human Single-Domain Antibodies against SARS-CoV-2." dans: Cell host & microbe, (2020) (PubMed).
: "Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2." dans: Genes & diseases, (2020) (PubMed).
: "SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus." dans: Communications biology, Vol. 4, Issue 1, pp. 129, (2021) (PubMed).
: "Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2." dans: JCI insight, (2021) (PubMed).
: "SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity." dans: Nature communications, Vol. 12, Issue 1, pp. 848, (2021) (PubMed).
: "Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2." dans: International immunopharmacology, Vol. 90, pp. 107172, (2021) (PubMed).
: "Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library." dans: Protein science : a publication of the Protein Society, Vol. 30, Issue 4, pp. 716-727, (2021) (PubMed).
: "A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency." dans: Antiviral research, Vol. 194, pp. 105147, (2021) (PubMed).
: "38" dans: , Vol. 1363, Issue Nucleic acids research, pp. 28-39, (1991)
: "Identification of Human Single-Domain Antibodies against SARS-CoV-2." dans: Cell host & microbe, (2020) (PubMed).
: "Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2." dans: Genes & diseases, (2020) (PubMed).
Pseudonymes pour ACE2 Protéines
angiotensin I converting enzyme (ACE) Protéinesangiotensin I converting enzyme 2 (ACE2) Protéines
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 (Ace2) Protéines
angiotensin I converting enzyme 2 (Ace2) Protéines
angiotensin I converting enzyme 2 (ace2) Protéines
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 (ACE2) Protéines
2010305L05Rik Protéines
ACE1 Protéines
ACEH Protéines
CD143 Protéines
DCP Protéines
DCP1 Protéines
ICH Protéines
MVCD3 Protéines
zgc:92514 Protéines
Avez-vous cherché autre chose?
- ACD Protéines
- ACCN5 Protéines
- ACCN4 Protéines
- ACCN1 Protéines
- ACBD7 Protéines
- ACBD6 Protéines
- ACBD5 Protéines
- ACBD4 Protéines
- ACBD3 Protéines
- ACAT2 Protéines
- ACAT1 Protéines
- ACAP1 Protéines
- ACADVL Protéines
- ACADSB Protéines
- ACADS Protéines
- ACADL Protéines
- Acad8 Protéines
- ACAD11 Protéines
- ACAD10 Protéines
- ACAA2 Protéines
- ACER1 Protéines
- ACER2 Protéines
- Acetoin Reductase Protéines
- Acetyl-CoA Carboxylase alpha Protéines
- Acetyl-CoA Carboxylase beta Protéines
- Acetylcholinesterase Protéines
- Achaete-Scute Complex Homolog 1 (Drosophila) Protéines
- ACIN1 Protéines
- ACLY Protéines
- ACMSD Protéines
- ACO2 Protéines
- Aconitase 1 Protéines
- ACOT1 Protéines
- ACOT11 Protéines
- ACOT12 Protéines
- ACOT4 Protéines
- ACOT6 Protéines
- ACOT7 Protéines
- ACOT8 Protéines
- ACOT9 Protéines
Vous êtes ici:
